Yes, DPP-4 inhibitors and GLP-1 receptor agonists can be used together in type 2 diabetes management
With Chennais harsh sun, rising pollution, and lifestyle stressors, skin dullness, pigmentation, and uneven skin tone are increasingly common
The flexible nature of IDPs and IDRs makes them particularly susceptible to a wide range of PTMs (Dunker et al., 2002
Similarly, studies on Danzhi-Xiaoyao-San indicate that it exerts an antidepressant effect by modulating the composition of the gut microbiota in patients with depression and influencing metabolic pathways [600]
Furthermore, we showed that results were similar in patients who commenced treatment with a lower dose of semaglutide and those who received a 1 mg dose at the time of switching
REFERENCES Du Y, Nomura Y, Luo N et al